Atypical meningioma
Information
- Disease name
- Atypical meningioma
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT02847559 | Recruiting | Phase 2 | Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma | August 2016 | August 2024 |
| NCT04541082 | Recruiting | Phase 1 | Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms | October 26, 2020 | February 2025 |
| NCT02973256 | Unknown status | Oncological Care for Patients With Meningioma | January 1, 2019 | December 30, 2023 | |
| NCT03016091 | Unknown status | Phase 2 | A Trial of Pembrolizumab for Refractory Atypical and Anaplastic Meningioma | February 20, 2018 | February 2022 |
| NCT04761653 | Unknown status | Study of the Inflammatory Microenvironment in Atypical Meningiomas | January 1, 2021 | June 30, 2021 |